The global immunoassay interference blocker market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for point-of-care diagnostics. The major players in the global immunoassay interference blocker market are Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Merck KGaA, Agilent Technologies, Inc, and Abbott Laboratories.
- The increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the immunoassay interference blocker market.
- The increasing number of immunoassays being used in clinical diagnostics is also driving the growth of this market.
- The growing demand for point-of-care testing devices is also a factor that will drive the growth of this market in future years.
- Increasing awareness about immunoassay interference blockers among healthcare professionals and patients will also drive the growth of this market in future years, as these drugs are used to prevent false positive results from interfering with diagnostic tests, which can lead to misdiagnosis or delayed diagnosis and treatment for serious conditions such as cancer or heart disease.
- Increasing research on new drug candidates for immunoassay interference blockers will also fuel the growth of this market.
Industry Growth Insights published a new data on “Immunoassay Interference Blocker Market”. The research report is titled “Immunoassay Interference Blocker Market research by Types (Antibody Interference Blockers, Detection Interference Blockers, Surface Interference Blockers, Others, ), By Applications (Academic & Research Institutes, Biotechnology Companies, Molecular Diagnostics Companies, ), By Players/Companies Abcam, AMS Biotechnology (Europe) Limited, Aviva Systems Biology, Bio-Rad Laboratories, Meridian Bioscience, Roche Diagnostics GmbH, Rockland Immunochemicals, Scantibodies Laboratory, Thermo Fisher Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunoassay Interference Blocker Market Research Report
By Type
Antibody Interference Blockers, Detection Interference Blockers, Surface Interference Blockers, Others,
By Application
Academic & Research Institutes, Biotechnology Companies, Molecular Diagnostics Companies,
By Companies
Abcam, AMS Biotechnology (Europe) Limited, Aviva Systems Biology, Bio-Rad Laboratories, Meridian Bioscience, Roche Diagnostics GmbH, Rockland Immunochemicals, Scantibodies Laboratory, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Immunoassay Interference Blocker Market Report Segments:
The global Immunoassay Interference Blocker market is segmented on the basis of:
Types
Antibody Interference Blockers, Detection Interference Blockers, Surface Interference Blockers, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Biotechnology Companies, Molecular Diagnostics Companies,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- AMS Biotechnology (Europe) Limited
- Aviva Systems Biology
- Bio-Rad Laboratories
- Meridian Bioscience
- Roche Diagnostics GmbH
- Rockland Immunochemicals
- Scantibodies Laboratory
- Thermo Fisher Scientific
Highlights of The Immunoassay Interference Blocker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody Interference Blockers
- Detection Interference Blockers
- Surface Interference Blockers
- Others
- By Application:
- Academic & Research Institutes
- Biotechnology Companies
- Molecular Diagnostics Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunoassay Interference Blocker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An immunoassay interference blocker is a molecule that can interfere with the ability of an antibody to bind to its target antigen. This can be useful in diagnostic tests, as it allows for the detection of antibodies against targets other than the intended target.
Some of the key players operating in the immunoassay interference blocker market are Abcam, AMS Biotechnology (Europe) Limited, Aviva Systems Biology, Bio-Rad Laboratories, Meridian Bioscience, Roche Diagnostics GmbH, Rockland Immunochemicals, Scantibodies Laboratory, Thermo Fisher Scientific.
The immunoassay interference blocker market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunoassay Interference Blocker Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Immunoassay Interference Blocker Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Immunoassay Interference Blocker Market - Supply Chain
4.5. Global Immunoassay Interference Blocker Market Forecast
4.5.1. Immunoassay Interference Blocker Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Immunoassay Interference Blocker Market Size (000 Units) and Y-o-Y Growth
4.5.3. Immunoassay Interference Blocker Market Absolute $ Opportunity
5. Global Immunoassay Interference Blocker Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Immunoassay Interference Blocker Market Size and Volume Forecast by Type
5.3.1. Antibody Interference Blockers
5.3.2. Detection Interference Blockers
5.3.3. Surface Interference Blockers
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Immunoassay Interference Blocker Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Immunoassay Interference Blocker Market Size and Volume Forecast by Application
6.3.1. Academic & Research Institutes
6.3.2. Biotechnology Companies
6.3.3. Molecular Diagnostics Companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Immunoassay Interference Blocker Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Immunoassay Interference Blocker Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Immunoassay Interference Blocker Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Immunoassay Interference Blocker Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Immunoassay Interference Blocker Demand Share Forecast, 2019-2026
9. North America Immunoassay Interference Blocker Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Immunoassay Interference Blocker Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Immunoassay Interference Blocker Market Size and Volume Forecast by Application
9.4.1. Academic & Research Institutes
9.4.2. Biotechnology Companies
9.4.3. Molecular Diagnostics Companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Immunoassay Interference Blocker Market Size and Volume Forecast by Type
9.7.1. Antibody Interference Blockers
9.7.2. Detection Interference Blockers
9.7.3. Surface Interference Blockers
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Immunoassay Interference Blocker Demand Share Forecast, 2019-2026
10. Latin America Immunoassay Interference Blocker Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Immunoassay Interference Blocker Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Immunoassay Interference Blocker Market Size and Volume Forecast by Application
10.4.1. Academic & Research Institutes
10.4.2. Biotechnology Companies
10.4.3. Molecular Diagnostics Companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Immunoassay Interference Blocker Market Size and Volume Forecast by Type
10.7.1. Antibody Interference Blockers
10.7.2. Detection Interference Blockers
10.7.3. Surface Interference Blockers
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Immunoassay Interference Blocker Demand Share Forecast, 2019-2026
11. Europe Immunoassay Interference Blocker Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Immunoassay Interference Blocker Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Immunoassay Interference Blocker Market Size and Volume Forecast by Application
11.4.1. Academic & Research Institutes
11.4.2. Biotechnology Companies
11.4.3. Molecular Diagnostics Companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Immunoassay Interference Blocker Market Size and Volume Forecast by Type
11.7.1. Antibody Interference Blockers
11.7.2. Detection Interference Blockers
11.7.3. Surface Interference Blockers
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Immunoassay Interference Blocker Demand Share, 2019-2026
12. Asia Pacific Immunoassay Interference Blocker Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Immunoassay Interference Blocker Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Immunoassay Interference Blocker Market Size and Volume Forecast by Application
12.4.1. Academic & Research Institutes
12.4.2. Biotechnology Companies
12.4.3. Molecular Diagnostics Companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Immunoassay Interference Blocker Market Size and Volume Forecast by Type
12.7.1. Antibody Interference Blockers
12.7.2. Detection Interference Blockers
12.7.3. Surface Interference Blockers
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Immunoassay Interference Blocker Demand Share, 2019-2026
13. Middle East & Africa Immunoassay Interference Blocker Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Immunoassay Interference Blocker Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Immunoassay Interference Blocker Market Size and Volume Forecast by Application
13.4.1. Academic & Research Institutes
13.4.2. Biotechnology Companies
13.4.3. Molecular Diagnostics Companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Immunoassay Interference Blocker Market Size and Volume Forecast by Type
13.7.1. Antibody Interference Blockers
13.7.2. Detection Interference Blockers
13.7.3. Surface Interference Blockers
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Immunoassay Interference Blocker Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Immunoassay Interference Blocker Market: Market Share Analysis
14.2. Immunoassay Interference Blocker Distributors and Customers
14.3. Immunoassay Interference Blocker Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abcam
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AMS Biotechnology (Europe) Limited
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aviva Systems Biology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bio-Rad Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Meridian Bioscience
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roche Diagnostics GmbH
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Rockland Immunochemicals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Scantibodies Laboratory
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook